Diseases, Conditions, Syndromes

Major COVID-19 vaccine trial resumes in UK after safety review

Pharma giant AstraZeneca and Oxford University on Saturday said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

Vaccination

Study finds vaccine hesitancy lower in poorer countries

New research published in Nature Medicine reveals willingness to get a COVID-19 vaccine was considerably higher in developing countries (80% of respondents) than in the United States (65%) and Russia (30%).

Diseases, Conditions, Syndromes

BioNTech says can make mutation-beating vaccine in six weeks

The co-founder of BioNTech said Tuesday it was "highly likely" that its vaccine against the coronavirus works against the mutated strain detected in Britain, but it could also adapt the vaccine if necessary in six weeks.

Vaccination

US regulators give full approval to Pfizer COVID-19 vaccine

The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations ...

Diseases, Conditions, Syndromes

Unusual late influenza spring-wave in Canada 2022

In a Eurosurveillance paper, researchers look into the impact of COVID-19 measures on influenza circulation in Canada between 2020 and 2022 and the vaccine effectiveness against late-season influenza illness due to A(H3N2) ...

page 1 from 6